Literature DB >> 1277123

Comparison of in vitro methods to determine drug-induced cell lethality.

P R Roper, B Drewinko.   

Abstract

In proliferating cell populations, the inability to reproduce indefinitely is the only relevant criterion to assess cell lethality. The in vitro colony formation technique (CF) used to determine reproductive death is, however, too slow and has several technical limitations. For finding suitable, more rapid techniques that assessed drug-induced cell killing, a human lymphoma cell line was exposed in vitro to increasing concentrations of adriamycin, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea for 1 hr. Survival was assayed immediately after treatment and at regular intervals thereafter. Data from CF were compared to those resulting from the following tests: doubling time, labeling index, dye exclusion, 51Cr release, and rate of [3H]thymidine uptake (scintillation index). Dye exclusion and 51Cr release failed to demonstrate any killing effect for the 3 drugs. The percentage of killing calculated from doubling time determinations, although dose dependent, failed to correlate with CF. Scintillation and labeling index values displayed similar temporal fluctuations but were not clearly dose dependent and did not correlate with CF. Thus, CF appears as the most reliable, dose-dependent index of cell lethality. Tests that measure metabolic death grossly overestimate or underestimate killing activity induced by 3 of the most effective antitumor drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Flow cytometric assessment of cell viability: a multifaceted analysis.

Authors:  E Combrier; P Métézeau; X Ronot; H Gachelin; M Adolphe
Journal:  Cytotechnology       Date:  1989-02       Impact factor: 2.058

2.  A semi-automated neutral red based chemosensitivity assay for drug screening.

Authors:  P F Cavanaugh; P S Moskwa; W H Donish; P J Pera; D Richardson; A P Andrese
Journal:  Invest New Drugs       Date:  1990-11       Impact factor: 3.850

3.  Chemosensitivity study of urological malignancies using a novel dye-exclusion method.

Authors:  K Naito; H Hisazumi; S Mihara; T Asari; K Kobashi; T Amano; T Uchibayashi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 4.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Inhibition of protein synthesis, pulmonary localization and pulmonary tumour formation by drug-treated tumour cells as a means of predicting their chemosensitivity.

Authors:  T Lai; B R Stonebridge; J Black; M O Symes
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

Review 6.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

7.  Growth kinetics of L1210 leukemic cells exposed to different concentration courses of methotrexate in vitro.

Authors:  S Gimmel; H R Maurer
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Chemotherapy sensitivity testing in human tumours.

Authors:  H G Richmond; R W Billington
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

Review 9.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

10.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.

Authors:  F R Ahmann; H S Garewal; R Schifman; A Celniker; S Rodney
Journal:  In Vitro Cell Dev Biol       Date:  1987-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.